Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
592 participants
INTERVENTIONAL
2007-12-06
2011-11-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prevention of Recurrence of Diverticulitis
NCT00545740
Phase 2 RCT of Alvimopan vs. Placebo After CRS/HIPEC
NCT03352414
A Safety and Efficacy Comparison of BLI4700 Bowel Preparation Versus an FDA-approved Comparator in Adult Subjects Prior to Colonoscopy
NCT03261960
A Safety and Efficacy Comparison of BLI4700 Bowel Prep Versus an FDA-approved Comparator in Adults Prior to Colonoscopy
NCT03404401
Asimadoline for the Treatment of Post-Operative Ileus
NCT00443040
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
SPD476 (1.2 g)
SPD476, MMX™ mesalazine, 1.2g extended release tablet
SPD476 1.2g administered Once Daily (QD)
SPD476 (2.4 g)
SPD476, MMX™ mesalazine, 2.4g extended release tablet
SPD476 2.4g administered Once Daily (QD)
SPD476 (4.8 g)
SPD476, MMX™ mesalazine, 4.8g extended release tablet
SPD476 4.8g administered Once Daily (QD)
Placebo
Placebo
Placebo administered Once Daily (QD)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SPD476, MMX™ mesalazine, 1.2g extended release tablet
SPD476 1.2g administered Once Daily (QD)
SPD476, MMX™ mesalazine, 2.4g extended release tablet
SPD476 2.4g administered Once Daily (QD)
SPD476, MMX™ mesalazine, 4.8g extended release tablet
SPD476 4.8g administered Once Daily (QD)
Placebo
Placebo administered Once Daily (QD)
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. If female of childbearing potential (FOCP), has demonstrated a negative beta HCG (human chorionic gonadotropin) serum pregnancy test, and agrees to comply with any applicable contraceptive requirements of the protocol
3. An episode of acute diverticulitis that resolved without colonic resection.
4. Confirmation of diverticulosis via endoscopic evaluation of the sigmoid colon with at least three diverticula noted
Exclusion Criteria
2. Active peptic ulcer disease
3. History of or current presence of inflammatory bowel disease (IBD)
4. Subjects with active irritable bowel syndrome (IBS) requiring ongoing medication
5. Allergy or hypersensitivity to aspirin or related compounds
6. Allergy to radiologic contrast agents
7. Use of another Investigational product within 30 days of Baseline
8. Use of antibiotic therapy within 4 weeks of Baseline
9. Within 14 days of Baseline, use of prebiotic, probiotic or 5-ASA medications, as well as drugs active at the 5HT-receptor or anti-spasmodic agents
10. Use of systemic or rectal steroids within 6 weeks of Baseline. Use of inhaled or nasal steroids is acceptable
11. Use of anti-inflammatory drugs, (NSIADs, COX-2 inhibitors) including aspirin (except for cardiac prophylaxis) and ibuprofen, on a regular and ongoing basis
12. History of alcohol or other substance abuse within the previous year
13. Active or recent history of endometriosis or dysmenorrhoea within 6 months prior to Baseline
14. Females who are lactating
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shire
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Study Director
Role: STUDY_DIRECTOR
Takeda
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Birmingham Gastroenterology Associates, PC
Birmingham, Alabama, United States
Alabama Clinical Therapeutics, LLC
Birmingham, Alabama, United States
Medical Affiliated Research Center, Inc
Huntsville, Alabama, United States
Alabama Digestive Disorders Center, PC
Huntsville, Alabama, United States
Genova Clinical Research
Tucson, Arizona, United States
Digestive and Liver Disease Specialists
Garden Grove, California, United States
High Desert Gastroenterology, Inc.
Lancaster, California, United States
VA Long Beach Healthcare System
Long Beach, California, United States
CA Physicians Research Alliance
Oceanside, California, United States
Digestive Care Medical Center
San Carlos, California, United States
Rider Research Group
San Francisco, California, United States
Huntington Medical Foundation
San Marino, California, United States
Clinical Research of the Rockies
Lafayette, Colorado, United States
Arapahoe Gastroenterology, PC
Littleton, Colorado, United States
Litchfield County Gastroenterology Associates, LLC
Torrington, Connecticut, United States
Madeleine DuPree, MD
Boynton Beach, Florida, United States
Palmetto Research LLC
Hialeah, Florida, United States
Mark Lamet, MD
Hollywood, Florida, United States
Digestive Disease Consultants
Maitland, Florida, United States
University of Miami Miller School of Medicine
Miami, Florida, United States
University of Miami
Miami, Florida, United States
Miami Research Associates
Miami, Florida, United States
United Medical Research
New Smyrna Beach, Florida, United States
West Wind'r Research & Development
Tampa, Florida, United States
Atlanta Gastroenterology Associates
Marietta, Georgia, United States
Gastrointestinal Clinical of Quad Cities
Davenport, Iowa, United States
Sunflower Medical Group
Mission, Kansas, United States
Kansas Medical Clinic
Topeka, Kansas, United States
Gastroenterology Associates, LLC
Baton Rouge, Louisiana, United States
Louisiana Research Center, LLC
Shreveport, Louisiana, United States
Maryland Clinical Trials
Annapolis, Maryland, United States
Chevy Chase Clinical Research
Chevy Chase, Maryland, United States
Mid Atlantic Medical Research Centers
Hollywood, Maryland, United States
Charm City Research, LLC
Lutherville, Maryland, United States
Shah Associates, LLC
Prince Frederick, Maryland, United States
Clinical Research Institute of Michigan, LLC
Chesterfield, Michigan, United States
Center for Digestive Health
Troy, Michigan, United States
Gastrointestinal Associates, PA
Jackson, Mississippi, United States
Center for Digestive & Liver Diseases, Inc
Mexico, Missouri, United States
Sundance Clinical Research
St Louis, Missouri, United States
The Gastroenterology Group of South Jersey
Vineland, New Jersey, United States
NY Center for Clinical Research
Lake Success, New York, United States
Concorde Medical Group
New York, New York, United States
Cumberland Research Associates
Fayetteville, North Carolina, United States
LeBauer Research Associates, PA
Greensboro, North Carolina, United States
Wake Research Associates
Raleigh, North Carolina, United States
Digestive Health Specialists
Winston-Salem, North Carolina, United States
Consultants for Clinical Research
Cincinnati, Ohio, United States
Digestive Specialists Inc.
Dayton, Ohio, United States
AMH Feasterville Family Health Care Center
Feasterville, Pennsylvania, United States
Digestive Disorders Center
Pittsburgh, Pennsylvania, United States
Clinsearch, LLC
Chattanooga, Tennessee, United States
Memphis Gastroenterology Group, PC
Germantown, Tennessee, United States
Houston Endoscopy and Research Center
Houston, Texas, United States
Hidalgo Clinical Research
San Antonio, Texas, United States
Physician Research Options
Murray, Utah, United States
Granite Peaks Gastroenterology
Sandy City, Utah, United States
Northwest Gastroenerology Associates
Bellevue, Washington, United States
Seattle Gastroenterology Associates
Seattle, Washington, United States
Instituto Goiano de Gastroenterologia e Endoscopia Digestiva Ltda.
Goiânia, Goiás, Brazil
Universidade Federal de Juiz de Fora
Juiz de Fora, Minas Gerais, Brazil
Hospital Universitário Clementino Fraga Filho
Rio de Janeiro, Rio de Janeiro, Brazil
Hospital de Clinicas de Porto Alegre
Porto Alegre, Rio Grande do Sul, Brazil
Hospital Sao Lucas PUCRS
Porto Alegre, Rio Grande do Sul, Brazil
Fundacao Universidade Federal do Rio Grande - Hopsital Universitario
Rio Grande, Rio Grande do Sul, Brazil
Unidade Integrada de Gastroenterologia UNIGASTRO
Campinas, São Paulo, Brazil
Irmandade da Santa Casa de Misericordia de Santos
Santos, São Paulo, Brazil
Hospital Universitario Pedro Ernesto
Rio de Janeiro, , Brazil
Centro de Pesquisas Clinicas- CPCLIN
São Paulo, , Brazil
Liver and Intestinal Research Centre
Vancouver, British Columbia, Canada
Topsail Road Medical Clinic
St. John's, Newfoundland and Labrador, Canada
Corunna Medical Research Centre
Corunna, Ontario, Canada
Cleveland Clinic Canada
Toronto, Ontario, Canada
Hotel-Dieu de Levis
Lévis, Quebec, Canada
Omnispec Clinical Research
Mirabel, Quebec, Canada
Hopital Maisonneuve-Rosemont
Montreal, Quebec, Canada
Gastroenterology Centre
Pointe-Claire, Quebec, Canada
Q&T Research
Sherbrooke, Quebec, Canada
Suomen Terveystalo Oyj
Jyväskylä, , Finland
Kuopio University Hospital
Kuopio, , Finland
Päijat-Häme Central Hospital
Lahti, , Finland
Oulu University Hospital
Oulu, , Finland
Vaasa Central Hospital
Vaasa, , Finland
Synexus ClinPharm GmbH Berlin
Berlin, Berlin (Hellersdorf), Germany
Gastrologische Gemeinschaftspraxis Herne im Ärztehaus am Evangelischen Krankenhaus Herne
Herne, Nord-Rhein-Wesfalen, Germany
Synexus ClinPharm International GmbH
Bochum, , Germany
Synexus ClinPharm International GmbH
Frankfurt, , Germany
Synexus ClinPharm International GmbH
Görlitz, , Germany
Universitätsklinikum Schleswig-Holstein
Kiel, , Germany
Synexus ClinPharm International GmbH
Leipzig, , Germany
Synexus ClinPharm International GmbH
Magdeburg, , Germany
Synexus ClinPharm International GmbH
Potsdam, , Germany
Peterfy Hospital, Dept. Of Gastroenterology
Budapest, , Hungary
University of Debrecen, 3rd Dept. Of Medicine
Debrecen, , Hungary
Bekes Megyei Kepviselotestulet Pandy Kalman Korhaza, Endoszkopos laboratorium
Gyula, , Hungary
Kaposi Mór Teaching Hospital
Kaposvár, , Hungary
Karolina Hospital, Dept. of Internal Medicine and Gastroenterology
Mosonmagyaróvár, , Hungary
Jávorszky Ödön Városi Kórhaz, II. Belgyógyászat
Vác, , Hungary
Ospedale Valduce
Como, , Italy
Ospedale Fatebenefratelli ed Oftalmico
Milan, , Italy
Universita degli Studi di Padova
Padua, , Italy
U.O. di Gastroenterologia ed Endoscopia digestiva Torre delle Medicine Azienda Ospedaliera di Parma
Parma, , Italy
Universita di Pavia Cattedra di Gastroenterologia Dipartimento di Medicina
Pavia, , Italy
Azienda Ospedaliera Universitaria Policlinico Tor Vergata
Roma, , Italy
San Camillo Forlanini
Roma, , Italy
Policlinico Univeritario A Gemelli
Roma, , Italy
Policlinico Univeritario A. Gemelli
Roma, , Italy
Meander Medisch Centrum
Amersfoort, , Netherlands
VU Medisch Centrum
Amsterdam, , Netherlands
Academisch Ziekenhuis Maastricht
Maastricht, , Netherlands
Ikazia Ziekenhuis
Rotterdam, , Netherlands
St. Jans Gashuis
Weert, , Netherlands
CMI de Gastroenterologie Dobru Daniela
Târgu Mureş, Mureș County, Romania
Spitalul Clinic "Dr. I. Cantacuzino"
Bucharest, , Romania
Institutul Clinic Fundeni
Bucharest, , Romania
Spitalul Universitar de Urgenta Bucuresti
Bucharest, , Romania
Centrul Medical Galenus
Târgu Mureş, , Romania
Cabinet Particular Policlinic Algomed SRL
Timișoara, , Romania
Policlinica "Dr. Citu" SRL
Timișoara, , Romania
Panorama Medi-Clinic
Cape Town, Western Cape, South Africa
Universitas Hospital
Bloemfontein, , South Africa
Harold Bloch
Cape Town, , South Africa
Panorama Medi-Clinic
Cape Town, , South Africa
Louis Leipoldt Medical Centre
Cape Town, , South Africa
Kingsbury Hospital
Cape Town, , South Africa
Parklands Medical Centre
Durban, , South Africa
Chelmsford Medical Centre 2
Durban, , South Africa
Milpark Hospital
Johannesburg, , South Africa
Linksfield Park Clinic
Johannesburg, , South Africa
Johannesburg General Hospital
Johannesburg, , South Africa
Kloof Medi-Clinic
Pretoria, , South Africa
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Raskin JB, Kamm MA, Jamal MM, Marquez J, Melzer E, Schoen RE, Szaloki T, Barrett K, Streck P. Mesalamine did not prevent recurrent diverticulitis in phase 3 controlled trials. Gastroenterology. 2014 Oct;147(4):793-802. doi: 10.1053/j.gastro.2014.07.004. Epub 2014 Jul 16.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2007-004896-20
Identifier Type: EUDRACT_NUMBER
Identifier Source: secondary_id
SPD476-314
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.